Victoria, British Columbia, Canada, July 18th, 2018 – To meet global demand, IMMUNOPRECISE ANTIBODIES LTD. (“ImmunoPrecise” or “IPA”) (TSX VENTURE: IPA) (OTC PINK: IPATF) accelerates the launch of its European B-cell facility expansion at its ModiQuest Research division in Oss, the Netherlands. The new B-cell facility has been launched ahead of schedule, in response to client … Continue reading